{"id":"https://openalex.org/W4304609175","doi":"https://doi.org/10.26434/chemrxiv-2022-5p97s-v2","title":"Chemical generation of checkpoint inhibitory T cell engagers (CiTEs) for the treatment of cancer","display_name":"Chemical generation of checkpoint inhibitory T cell engagers (CiTEs) for the treatment of cancer","publication_year":2022,"publication_date":"2022-10-11","ids":{"openalex":"https://openalex.org/W4304609175","doi":"https://doi.org/10.26434/chemrxiv-2022-5p97s-v2"},"language":"en","primary_location":{"id":"doi:10.26434/chemrxiv-2022-5p97s-v2","doi":"https://doi.org/10.26434/chemrxiv-2022-5p97s-v2","is_oa":true,"landing_page_url":"https://doi.org/10.26434/chemrxiv-2022-5p97s-v2","pdf_url":null,"source":{"id":"https://openalex.org/S4393918830","display_name":"ChemRxiv","issn_l":"2573-2293","issn":["2573-2293"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.26434/chemrxiv-2022-5p97s-v2","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032462971","display_name":"P\u00e9ter A. Szijj","orcid":"https://orcid.org/0000-0002-2944-2676","observed_orcids":["https://orcid.org/0000-0002-2944-2676"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Peter A. Szijj","raw_affiliation_strings":["University College London"],"raw_orcid":"https://orcid.org/0000-0002-2944-2676","affiliations":[{"raw_affiliation_string":"University College London","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054708491","display_name":"Melissa Anne Gray","orcid":"https://orcid.org/0000-0002-7700-1090","observed_orcids":["https://orcid.org/0000-0002-7700-1090"]},"institutions":[{"id":"https://openalex.org/I1344073410","display_name":"Howard Hughes Medical Institute","ror":"https://ror.org/006w34k90","country_code":"US","type":"facility","lineage":["https://openalex.org/I1344073410"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa A. Gray","raw_affiliation_strings":["Howard Hughes Medical Institute","Sarafan ChEM-H","Stanford University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Howard Hughes Medical Institute","institution_ids":["https://openalex.org/I1344073410"]},{"raw_affiliation_string":"Sarafan ChEM-H","institution_ids":[]},{"raw_affiliation_string":"Stanford University","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019077939","display_name":"Mikaela K. Ribi","orcid":"https://orcid.org/0000-0001-6816-8326","observed_orcids":["https://orcid.org/0000-0001-6816-8326"]},"institutions":[{"id":"https://openalex.org/I1344073410","display_name":"Howard Hughes Medical Institute","ror":"https://ror.org/006w34k90","country_code":"US","type":"facility","lineage":["https://openalex.org/I1344073410"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mikaela K. Ribi","raw_affiliation_strings":["Howard Hughes Medical Institute","Sarafan ChEM-H","Stanford University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Howard Hughes Medical Institute","institution_ids":["https://openalex.org/I1344073410"]},{"raw_affiliation_string":"Sarafan ChEM-H","institution_ids":[]},{"raw_affiliation_string":"Stanford University","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003057326","display_name":"Calise Bahou","orcid":"https://orcid.org/0000-0002-3243-0887","observed_orcids":["https://orcid.org/0000-0002-3243-0887"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Calise Bahou","raw_affiliation_strings":["University College London"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064538788","display_name":"Jo\u00e3o C. F. Nogueira","orcid":"https://orcid.org/0000-0002-5992-5900","observed_orcids":["https://orcid.org/0000-0002-5992-5900"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jo\u00e3o C. F. Nogueira","raw_affiliation_strings":["University College London"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088409133","display_name":"Carolyn Ruth Bertozzi","orcid":"https://orcid.org/0000-0003-4482-2754","observed_orcids":["https://orcid.org/0000-0003-4482-2754"]},"institutions":[{"id":"https://openalex.org/I1344073410","display_name":"Howard Hughes Medical Institute","ror":"https://ror.org/006w34k90","country_code":"US","type":"facility","lineage":["https://openalex.org/I1344073410"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carolyn R. Bertozzi","raw_affiliation_strings":["Howard Hughes Medical Institute","Sarafan ChEM-H","Stanford University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Howard Hughes Medical Institute","institution_ids":["https://openalex.org/I1344073410"]},{"raw_affiliation_string":"Sarafan ChEM-H","institution_ids":[]},{"raw_affiliation_string":"Stanford University","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075237619","display_name":"Vijay Chudasama","orcid":"https://orcid.org/0000-0002-8876-3285","observed_orcids":["https://orcid.org/0000-0002-8876-3285"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Vijay Chudasama","raw_affiliation_strings":["University College London"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London","institution_ids":["https://openalex.org/I45129253"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.8852999806404114,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.8852999806404114,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.04320000112056732,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11440","display_name":"Click Chemistry and Applications","score":0.019500000402331352,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.9120000004768372},{"id":"https://openalex.org/keywords/anti-pd-1-antibody","display_name":"anti-PD-1","score":0.7319999933242798},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.5979999899864197},{"id":"https://openalex.org/keywords/cd3","display_name":"CD3","score":0.8619999885559082},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7269999980926514},{"id":"https://openalex.org/keywords/pd-1-pd-l1-blockade","display_name":"PD-1/PD-L1 blockade","score":0.8230000138282776}],"concepts":[{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.534354567527771},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.4940841495990753},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.47980692982673645},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4605812728404999},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.43600988388061523},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.41351693868637085},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3661826252937317},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.340050607919693},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.330122709274292},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23141366243362427},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.153763085603714},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09298652410507202}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.26434/chemrxiv-2022-5p97s-v2","doi":"https://doi.org/10.26434/chemrxiv-2022-5p97s-v2","is_oa":true,"landing_page_url":"https://doi.org/10.26434/chemrxiv-2022-5p97s-v2","pdf_url":null,"source":{"id":"https://openalex.org/S4393918830","display_name":"ChemRxiv","issn_l":"2573-2293","issn":["2573-2293"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.26434/chemrxiv-2022-5p97s-v2","doi":"https://doi.org/10.26434/chemrxiv-2022-5p97s-v2","is_oa":true,"landing_page_url":"https://doi.org/10.26434/chemrxiv-2022-5p97s-v2","pdf_url":null,"source":{"id":"https://openalex.org/S4393918830","display_name":"ChemRxiv","issn_l":"2573-2293","issn":["2573-2293"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1293382753","display_name":null,"funder_award_id":"175282, 214941/Z/18/Z","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"},{"id":"https://openalex.org/G5097889547","display_name":null,"funder_award_id":"RPG-2020-010","funder_id":"https://openalex.org/F4320319993","funder_display_name":"Leverhulme Trust"},{"id":"https://openalex.org/G9000910461","display_name":"Targeting the cancer glycocalyx","funder_award_id":"R01CA227942","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"},{"id":"https://openalex.org/F4320319993","display_name":"Leverhulme Trust","ror":"https://ror.org/012mzw131"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4385224214","https://openalex.org/W4393093919","https://openalex.org/W3198985370","https://openalex.org/W2127132803","https://openalex.org/W4388653082","https://openalex.org/W3128974378","https://openalex.org/W4362541075","https://openalex.org/W2072449326","https://openalex.org/W3204952209","https://openalex.org/W7160725996"],"abstract_inverted_index":{"Bispecific":[0],"antibodies":[1],"(bsAbs)":[2],"provide":[3,28],"enticing":[4],"therapeutic":[5],"opportunities":[6],"in":[7,13,285,313],"the":[8,14,64,72,84,133,146,182,205,224,277,293,297],"area":[9],"of":[10,16,33,63,74,83,135,250,300,303],"immunotherapy,":[11],"especially":[12,280,311],"field":[15],"immuno-oncology.":[17],"These":[18,236],"constructs":[19,211,237],"can":[20,87],"bind":[21],"two":[22,183,215],"separate":[23],"antigenic":[24],"epitopes":[25],"and":[26,93,118,148,234,248,270],"thus":[27],"access":[29],"to":[30,51,61,89,151,180,185,197,256,265,273,295],"unique":[31],"mechanisms":[32],"action":[34],"(MoAs).":[35],"A":[36],"key":[37],"MoA":[38],"is":[39],"unlocked":[40],"by":[41,145,171],"bispecific":[42],"T":[43,49,113],"cell":[44],"engagers":[45],"(BiTEs),":[46],"which":[47,306],"cause":[48],"cells":[50],"be":[52,274,310,320],"cross-linked":[53],"with":[54,77,104,239,276],"a":[55,75,90,99,142,193,266,301],"targeted":[56,65],"cancer":[57],"cell,":[58],"ultimately":[59],"leading":[60],"death":[62],"cell.":[66],"It":[67],"has":[68,292],"been":[69,110,122,138],"shown":[70,255,272],"that":[71],"combination":[73],"BiTE":[76,100,268],"checkpoint":[78],"inhibition,":[79],"such":[80,216],"as":[81],"blockade":[82],"PD-1/PD-L1":[85],"pathway,":[86],"lead":[88],"synergistic":[91],"effect":[92],"greater":[94],"efficacy.":[95],"Constructs":[96],"built":[97],"from":[98,156],"core":[101],"(anti-CD3/anti-cancer":[102],"antigen)":[103],"an":[105,221,227],"immunomodulatory":[106,228],"protein":[107,125,252],"added,":[108],"have":[109,120,137],"dubbed":[111],"checkpoint-inhibitory":[112],"cell-engagers":[114],"(CiTEs).":[115],"Both":[116],"bsAbs":[117,136,155],"CiTEs":[119],"traditionally":[121],"generated":[123,212],"via":[124],"engineering.":[126],"However,":[127],"recently,":[128],"improved":[129],"chemical":[130,195,288],"methods":[131],"for":[132,166,244,323],"construction":[134],"reported.":[139],"This":[140],"includes":[141],"strategy":[143],"developed":[144],"Chudasama":[147],"Baker":[149],"groups":[150],"synthesize":[152],"homogenous":[153],"fragment-based":[154],"antibodies\u2019":[157],"fragments":[158],"antigen":[159],"binding":[160],"(Fabs),":[161],"utilising":[162],"click-enabled":[163],"pyridazinediones":[164],"(PDs)":[165],"functional":[167],"disulfide":[168],"re-bridging,":[169],"followed":[170],"strain-promoted":[172],"inverse":[173],"electron-demand":[174],"Diels-Alder":[175],"cycloaddition":[176],"(SPIEDAC)":[177],"click":[178],"chemistry":[179],"attach":[181],"Fabs":[184],"each":[186,249],"other.":[187],"In":[188],"this":[189],"paper,":[190],"we":[191,307],"describe":[192],"first-in-class":[194],"method":[196,289],"generate":[198],"biotin-functionalized":[199],"three-protein":[200,210],"conjugates,":[201],"building":[202],"significantly":[203,282],"on":[204],"previously":[206],"described":[207,290],"PD-method.":[208],"The":[209,287],"here":[213,291],"include":[214],"CiTE":[217,279],"molecules,":[218],"one":[219],"containing":[220,226],"anti-PD-1":[222],"Fab,":[223],"other":[225],"enzyme":[229],"Salmonella":[230],"typhimurium":[231],"sialidase;":[232],"FabCD3-FabHER2-FabPD-1-Biotin":[233],"FabHER2-FabCD3-Sia-Biotin.":[235],"(along":[238],"suitable":[240],"controls)":[241],"were":[242,254],"tested":[243],"their":[245,251,258],"biological":[246],"activity,":[247],"components":[253],"retain":[257],"function.":[259],"Their":[260],"efficacy":[261],"was":[262,271],"also":[263,318],"compared":[264],"simpler":[267],"scaffold":[269],"superior,":[275],"sialidase-containing":[278],"showing":[281],"enhanced":[283],"potency":[284],"vitro.":[286],"potential":[294],"enable":[296],"rapid":[298],"generation":[299],"plethora":[302],"multi-protein":[304],"constructs,":[305],"envisage":[308],"would":[309],"useful":[312],"hit-identification":[314],"screening":[315],"but":[316],"could":[317],"potentially":[319],"scaled":[321],"up":[322],"drug-development":[324],"after":[325],"further":[326],"optimization.":[327]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2022-10-12T00:00:00"}